AF
ICVX

Amalgamated Financial’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Amalgamated Financial’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$18K Buy
+2,573
New +$40.5K ﹤0.01% 2776

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Amalgamated Financial's ICVX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Icosavax, Inc. Common Stock (ICVX) in Q1 2022: 2,573 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #2776 among its holdings.

65 funds tracked by Wall St. Rank hold ICVX as of Q1 2022.

  • Amalgamated Financial held 2,573 shares of Icosavax, Inc. Common Stock worth $18K as of Q1 2022.
  • Icosavax, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Icosavax, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2776 holding.
  • 65 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.